Protalix生物治疗技术结合了Russell 3000和2000指数,提高了投资管理人员的可见度。 Protalix BioTherapeutics joins Russell 3000 and 2000 Indexes, boosting visibility for investment managers.

2025年6月27日生效的Russell 3000和Russell 2000索引中增加了生物制药公司Protalix生物治疗公司。 Protalix BioTherapeutics, a biopharmaceutical company, was added to the Russell 3000 and Russell 2000 Indexes, effective June 27, 2025. 在一年一度的重组之后,这种纳入可以提高公司在投资管理人员和以这些指数作为基准的机构投资者中的知名度。 This inclusion, following an annual reconstitution, could increase the company's visibility among investment managers and institutional investors who use these indexes as benchmarks. Russell指数涵盖美国最大的股票,使用的资产超过10万亿美元。 The Russell indexes cover the largest US stocks and are used by over $10 trillion in assets.